Repligen (NASDAQ:RGEN – Get Free Report) had its target price boosted by equities research analysts at JPMorgan Chase & Co.
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...
M onday saw Cantor Fitzgerald reaffirm its Overweight rating on NVIDIA (NASDAQ:NVDA) stock, keeping the price target steady at $200.00. The firm's endorsement comes amidst NVIDIA's advancements in ...